All Articles

S&P Global’s appointment of former PwC Global Chairman Robert Moritz aims to bolster risk management and governance as the company navigates a complex economic landscape and expands its ‘Essential Intelligence’ offerings.

A breakthrough allogeneic stem cell therapy from Gallant Therapeutics is on track for FDA approval, offering hope for cats suffering from a painful and chronic oral disease – and potentially ushering in a new era of veterinary regenerative medicine.

Femasys Inc. received a significant financial boost and European regulatory approvals for its innovative, non-surgical permanent birth control device, FemBloc, potentially disrupting the contraception market.

Venmo is rolling out a new cash-back rewards program designed to entice users to direct deposit their paychecks. But experts warn the move, while appealing, raises serious questions about data privacy and potential regulatory scrutiny.

A growing demand for proactive security is fueling adoption of AI-driven surveillance in apartment communities. Cloudastructure’s recent contract highlights the potential – and challenges – of this rapidly evolving market.

Dwight Global has been named the #1 Best Private Online School. But in a crowded market, what sets it apart—and what does this ranking signal for the future of education?

Gabb Music isn't just filtering explicit lyrics – it's proactively building a worry-free streaming experience for children. We delve into the tech and philosophy behind this rising player in the kid-safe tech space.

Flavia, the workplace beverage system from Lavazza, is expanding its offerings beyond coffee and tea with the launch of a new hot cocoa. This move highlights a growing trend in the single-serve market towards greater variety and indulgence.

The Toy Association’s TAGIE Awards celebrated groundbreaking design, enduring creativity, and the booming ‘kidult’ market. POP MART, iconic designers, and rising stars were among the honorees.

Ernexa Therapeutics is moving forward with its novel cell therapy for platinum-resistant ovarian cancer, but faces a crowded field and financial hurdles. A deep dive into the company's progress and challenges.

Biotech firm Cadence Therapeutics seeks to redefine anticoagulation for high-risk patients, but faces a looming ‘going concern’ warning and a competitive landscape rocked by recent trial setbacks.

As open source software becomes ubiquitous, a surge in collaborative security efforts – spearheaded by the OpenSSF – aims to address growing threats, including vulnerabilities in the AI supply chain. Companies like Target are joining the effort.

Ruder Finn’s new AI-powered content creation studio, rf.StoryLab, is pushing boundaries with innovative partnerships. But as AI integration deepens, questions about data privacy and responsible use emerge.

A Dutch biotech firm is leveraging artificial intelligence and cell-free technology to revolutionize hyaluronic acid production, potentially offering a more sustainable and cost-effective alternative to traditional fermentation.

Genius Group’s ambitious ‘Genius City’ project in Bali aims to revolutionize education with AI, blockchain, and a ‘Bitcoin-first’ community. But navigating Indonesian crypto regulations will be key.

Ball Corporation taps supply chain veteran Ronald J. Lewis as its new CEO, signaling a strategic focus on operational efficiency and sustainability amid shifting market demands and a robust packaging industry.

For nearly four decades, Project SHARE has bridged the gap between financial hardship and essential utilities for Georgians. A look at how this unique partnership is evolving to meet growing needs.

Genpact’s partnership with Celonis is driving significant value for clients through scaled AI deployments. This award recognizes a strategy shifting from pilot projects to enterprise-wide transformation.

A new cybersecurity framework for drones and robotics aims to address escalating threats and meet stringent new Department of Defense requirements, potentially reshaping the future of unmanned systems security.

Australian biotech Vaxxas is poised to revolutionize vaccine delivery with its innovative HD-MAP technology. A new manufacturing facility and positive clinical trial data signal a potential shift in global health access.